[Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist]

Z Rheumatol. 1998 Oct;57(5):312-9. doi: 10.1007/s003930050118.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Male
  • Middle Aged
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Receptors, Interleukin-1 / physiology
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use*
  • Sialoglycoproteins / adverse effects
  • Sialoglycoproteins / therapeutic use*

Substances

  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Interleukin-1
  • Recombinant Proteins
  • Sialoglycoproteins